Clinical Study

Biomarker Profile Does Not Predict Weight Loss Success in Successful and Unsuccessful Diet-Reduced Obese Individuals: A Prospective Study

Table 2

Hormone and cytokine levels before and after weight loss.

Subject characteristics and analytesa≥8% WLG<8% WLG
Baseline
( )
4 months
( )
Baseline
( )
4 months
( )

Weight (kg)87.9 ± 12.678.2 ± 11.489.7 ± 15.888.4 ± 18.8b
BMI (kg/m2)31.6 ± 3.528.27 ± 3.3232.4 ± 4.331.51 ± 5.51b
Amylin (pg/mL)38.3 (24.6–59.4)41.0 (26.3–64.1)24.4 (11.3–52.7)21.8 (8.4–56.6)
C-Peptide (pg/mL)1,030 (852–1,244)891 (736–1,077)c904 (649–1,260)948 (663–1,356)
GIP (pg/mL)93.8 (84.5–104.1)89.8 (80.8–99.8)83.3 (69.4–99.9)90.2 (71.7–113.4)
Ghrelin (pg/mL)28.2 (24.0–33.1)32.6 (27.6–38.4)23.8 (17.95–31.6)28.2 (19.3–41.1)
GLP-1 (pg/mL)7.90 (5.73–10.89)7.50 (5.42–10.38)4.83 (2.75–8.47)4.46 (2.28–8.73)
IL-6 (pg/mL)2.48 (1.91–3.24)2.83 (2.16–3.70)2.73 (1.72–4.33)1.71 (0.93–3.13)
Insulin (pg/mL)665 (573–772)541 (465–628)c532 (410–690)461 (339–626)
Leptin (ng/mL/kg fat)d0.83 (0.70–0.98)0.58 (0.49–0.69)c0.84 (0.62–1.13)0.87 (0.61–1.23)e,f
MCP-1 (pg/mL)81.5 (74.5–89.2)81.6 (74.5–89.4)86.0 (73.5–100.7)72.96 (60.3–88.3)
PP (pg/mL)81.3 (55.8–118.6)64.8 (44.2–94.9)57.7 (29.8–111.6)44.4 (20.1–97.99)
PYY (pg/mL)44.6 (33.1–60.1)45.4 (33.5–61.5)51.7 (30.6–87.2)40.6 (21.0–78.4)
TNF-α (pg/mL)3.76 (3.34–4.22)3.86 (3.43–4.35)3.72 (3.04–4.57)3.24 (2.48–4.24)

WLG: weight loss group; GIP: gastric inhibitory peptide; GLP: glucagon-like peptide; IL: interleukin; MCP: monocyte chemotactic protein; PP: pancreatic polypeptide; PYY: peptide YY; TNF-α: tumor necrosis factor-alpha.
aMean ± SD for subject characteristics and geometric mean (95% confidence interval) for analytes.
b for difference in change from baseline to 4 months between weight loss groups.
c for ratio of baseline to 4-month measurements within weight loss group.
dAdjusted for fat mass.
e for difference between 4-month measurements between weight loss groups.
f for difference in change from baseline to 4 months between weight loss groups.